Literature DB >> 24607053

Use of abatacept in eosinophilic asthma.

Rami Abdelshaeed1, Gregory B Griffiths2, Helen Neighbour3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24607053     DOI： 10.1016/j.jaip.2013.10.006

Source DB:  PubMed          Journal:  J Allergy Clin Immunol Pract


× No keyword cloud information.
  2 in total

1.  Intranasal administration of abatacept enhances IL-35+ and IL-10+ producing Bregs in lung tissues of ovalbumin-sensitized asthmatic mice model.

Authors:  Maha Fahad Alenazy; Fatemeh Saheb Sharif-Askari; Mohammed S El-Wetidy; Narjes Saheb Sharif-Askari; Ibrahim Yaseen Hachim; Mohammad-Hani Temsah; Basema Saddik; Roua Al-Kufaidy; Maha A Omair; Yasser A Alshawakir; Amany Adulgadel Fathaddin; Suad Hannawi; Qutayba Hamid; Mohammed A Omair; Saleh Al-Muhsen; Rabih Halwani
Journal:  PLoS One       Date:  2022-09-06       Impact factor: 3.752

2.  dNP2-ctCTLA-4 inhibits German cockroach extract-induced allergic airway inflammation and hyper-responsiveness via inhibition of Th2 responses.

Authors:  Sangho Lim; Jung Ho Sohn; Ja-Hyun Koo; Jung-Won Park; Je-Min Choi
Journal:  Exp Mol Med       Date:  2017-08-04       Impact factor: 8.718
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.